News

Valneva Enhances Chikungunya Vaccine ACIP Guidelines for Travelers

Valneva Enhances Chikungunya Vaccine ACIP Guidelines for Travelers

Valneva's Chikungunya Vaccine IXCHIQ and ACIP Updates

Valneva SE, recognized for its innovative vaccine solutions, has announced a pivotal update regarding its chikungunya vaccine IXCHIQ. During a routine meeting, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) provided new guidance on the use of this vaccine, especially for U.S. travelers. With the rise of chikungunya outbreaks globally, this recommendation holds great significance for public health.

ACIP Recommendations and Guidelines

As per the latest ACIP meeting, IXCHIQ now has a reaffirmed recommendation for individuals aged 18 and older who are traveling to regions experiencing chikungunya outbreaks. Additionally, ACIP suggests that the vaccine may also be appropriate for those planning to stay in areas with a heightened risk of chikungunya, even if an outbreak has not been reported, particularly for extended trips lasting six months or more. These updates showcase the commitment to prioritize health and safety for U.S. travelers.

Precaution for Older Adults

The ACIP also advised increased caution for individuals aged 65 and older. This decision comes on the heels of an ongoing investigation into reported severe adverse events among this age group following IXCHIQ vaccination. Although only a few cases have been documented through the Vaccine Adverse Event Reporting System (VAERS), including hospitalizations, all patients had underlying health conditions that may have contributed to their severe reactions.

Commitment to Safety and Ongoing Monitoring

Juan Carlos Jaramillo, M.D., the Chief Medical Officer at Valneva, expressed the company's dedication to safety. He indicated that the safety profile of IXCHIQ remains favorable, and the company respects ACIP's recommendation. Valneva is keen to ensure that healthcare providers assess each patient’s medical history and travel plans before administering the vaccine, emphasizing the importance of a thorough evaluation.

Valneva's Role in Managing Chikungunya

In response to the chikungunya outbreaks, Valneva has taken proactive steps to supply vaccines to areas in need. Notably, in recent weeks, they delivered 40,000 doses of IXCHIQ to France's La Réunion Island. The local public health agency has identified adults aged 65 and over, especially those with pre-existing conditions, as a priority group for vaccination to curb the ongoing outbreak effectively. Additionally, Valneva will provide an extra 50,000 doses to assist ongoing health initiatives.

Global Supply and Safety Monitoring

To date, Valneva has distributed approximately 80,000 doses of IXCHIQ across the U.S., Canada, and Europe. Since January 2025, no significant adverse events have been reported globally. Valneva's commitment to safety is showcased in their ongoing post-marketing surveillance, which includes routine safety reports to the U.S. Food and Drug Administration (FDA).

Understanding Chikungunya: The Threat

Chikungunya virus (CHIKV) is a dengue-like viral infection spread by Aedes mosquitoes. Symptoms often include high fever, debilitating joint pain, and other flu-like symptoms. Since it first surged in the early 2000s, chikungunya has posed a significant public health challenge, affecting millions across the globe. Given the establishment of CHIKV in over 110 countries, the WHO identifies it as a noteworthy concern, especially with rising global temperatures expanding mosquito habitats and increasing transmission rates.

Valneva's Vision and Impact on Global Health

Valneva SE is at the forefront of the vaccine industry, focusing on unmet medical needs through advanced research and development. Their portfolio includes the world’s first chikungunya vaccine, and a commitment to pushing the boundaries of vaccine technology. The company's robust pipeline includes candidates for various infectious diseases, demonstrating a strong commitment to public health and innovation.

Frequently Asked Questions

What is the current recommendation for Valneva's chikungunya vaccine?

The ACIP recommends IXCHIQ for individuals aged 18 and older traveling to areas with chikungunya outbreaks, with added caution for those aged 65 and older.

How is Valneva responding to reported adverse events?

Valneva is monitoring adverse events closely and works with regulatory bodies like the FDA to ensure the safety of IXCHIQ.

Where is Valneva supplying its chikungunya vaccine?

Valneva has distributed IXCHIQ in the U.S., Canada, and Europe, recently focusing on areas like France's La Réunion Island during outbreaks.

What type of health issues does chikungunya cause?

Chikungunya virus causes severe joint pain, fever, and other flu-like symptoms, which can persist for weeks to years.

How does Valneva ensure vaccine safety?

Valneva employs rigorous post-marketing safety monitoring and adheres to strict safety protocols during vaccine distribution and administration.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 211

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 163

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Chicago Auto Show: Run & Explore Indoors This February

Updated Category News Views 188

Nobody’s thinking about running laps when they walk into a colossal auto show, but the Chicago Auto Show isn't letting the pedal ease off the gas. Swing by on February 14, folks, for something not typically seen on the floors of McCormick Place. Run participants have got one hour to log as many miles as they can on the 2.4-mile loop right inside the show. Why a Running...

Continue Reading
Operation Healing Forces Partners with Wounded Warrior

Updated Category News Views 68

Joining Forces for Special Operations Families When it comes to the heavy lifting of supporting Special Operations Forces (SOF) families, two powerhouses—Operation Healing Forces (OHF) and Wounded Warrior Project (WWP)—are doubling down. They’re not just tossing around good intentions. Oh no, they’re pulling out the stops with a solid partnership focused on...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 81

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
Cardio Partners Hits a Million Milestone with Red Cross

Updated Category News Views 85

One Million Trained, One Million Prepared Ah, a million sounds like just another number, doesn't it? But when someone's life hangs in the balance, those are a million folks ready to jump in and act. Cardio Partners has hit this mighty milestone in CPR, AED, and First Aid training, gaining a pat on the back from none other than the American Red Cross. It's a testament,...

Continue Reading
Sandals Foundation: Win a Trip, Boost Caribbean Education

Updated Category News Views 226

Sandals Resorts Stakes a Claim in Education While the rest of us are gravitating towards Black Friday deals and Cyber Monday sales, the Sandals Foundation decided to play a different game. This Giving Tuesday, they invite travelers not just to soak in the sun, but to spread a little of it around by supporting education for kids across the Caribbean. It's a classic example...

Continue Reading
DHL Leverages Robust Growth in Resilient Supply Chains

Updated Category News Views 158

Supply Chain Resilience: A Strategic Game Changer Market volatility's got its teeth in the game, and everyone in logistics knows it. DHL Supply Chain isn't just sitting back; they're riding the wave of change, snagging a 12% revenue bump in 2026. It's not your typical headline growth, either. More like the kind of growth that gets logistics gurus eyeing those contract...

Continue Reading
Neil deGrasse Tyson Headlines HIMSS27 with Cosmic Insights

Updated Category News Views 237

celebrated science communicator, is set to close out the HIMSS27 conference with a keynote that's bound to leave a lasting impression. It's a fitting intersection of stars and stethoscopes, as the astrophysicist brings his expansive lens to the nitty-gritty of healthcare innovation. Splicing Science with Storytelling Folks, this ain't your standard healthcare gathering....

Continue Reading
PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 101

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading

Top 5 Most Recently Viewed Articles

Easterly ROCMuni Fund Investors: Understanding Your Rights

Updated Category News Views 110

Understanding the Easterly ROCMuni Fund Situation The Easterly ROCMuni High Income Municipal Bond Fund, formerly known as Principal Street High Income Municipal Fund, has recently come under scrutiny regarding its investment practices. Investors in the fund are encouraged to reach out to legal professionals to discuss potential claims related to significant financial...

Continue Reading
Is Bitcoin Ready for a Breakout Amid Bullish Sentiment?

Updated Category News Views 111

Bitcoin's Current Market Position Bitcoin (BTC/USD) is currently positioned near $115,000, just a day before significant decisions regarding interest rates by the Federal Reserve. Expectations are high, as many anticipate a rate cut of 25 basis points, which is igniting market discussions and predictions. Current Market Sentiment Recent data from Santiment highlights an...

Continue Reading
Nyxoah's Upcoming Presentation at Healthcare Conference Revealed

Updated Category News Views 168

Nyxoah to Present at Healthcare Conference Nyxoah SA, a leader in medical technology focused on treating Obstructive Sleep Apnea (OSA), is poised to showcase its advancements at an upcoming prominent event. The company will take part in the Piper Sandler 36th Annual Healthcare Conference, scheduled for December 4. This notable event is set to provide a platform for Nyxoah...

Continue Reading
Keros Therapeutics Welcomes Dr. Yung H. Chyung as CMO

Updated Category News Views 176

Keros Therapeutics Welcomes New Leadership Keros Therapeutics, Inc. (NASDAQ: KROS) is making waves with the recent appointment of Dr. Yung H. Chyung as their new Chief Medical Officer. This pivotal move signals the company's commitment to advancing its innovative drug development efforts, especially as they gear up for critical clinical milestones. Keros is known for its...

Continue Reading
Nestlé's Strategic Shake-Up: Leadership Changes and Impacts

Updated Category News Views 303

Unexpected Leadership Change at Nestlé In a surprising turn of events, Nestlé has dismissed its Chief Executive Officer, Laurent Freixe, due to his failure to communicate a romantic relationship with an employee who worked under his supervision. This decision highlights the strict adherence to corporate governance rules that Nestlé aims to uphold. Philipp Navratil...

Continue Reading